Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Manzano

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Critical Care Medicine|June 1, 1989
Pulmonary hypertension in acute respiratory failureJ Villar, M A Blazquez, S Lubillo, et al.
European Urology|January 1, 1997
T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activatedE Reyes, J Carballido, A Prieto, et al.
Revista Clinica Espanola|April 1, 1996
[Mounier-Kuhn syndrome. 2 representative cases of its clinical spectrum]J A Arranz Caso, J Fernández Francés, D Jiménez Jurado, et al.
British Journal of Cancer|January 1, 1997
Prophylactic intracavitary treatment with interferon alpha increases interferon gamma production by peripheral blood mononuclear cells in patients with superficial transitional cell carcinoma of the bladderL Moltó, J Carballido, L Manzano, et al.
British Journal of Cancer|March 31, 1999
The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patientsE Reyes, J Carballido, L Manzano, et al.
Cancer|June 1, 1995
Use of intracavitary interferon-alpha-2b in the prophylactic treatment of patients with superficial bladder cancerL Moltó, M Alvarez-Mon, J Carballido, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1994
Interferon beta enhances the natural killer activity of patients with bladder carcinomaL Moltó, J Carballido, L Manzano, et al.
Anti-Cancer Drugs|May 1, 1992
Immunomodulatory effect of interferon-alpha 2b on natural killer cells and T lymphocytes from patients with transitional cell carcinoma of the bladderM Alvarez-Mon, L M Moltó, L Manzano, et al.
Semergen|November 21, 2016
[Orthostatic hypotension; that great unknown]S M Velilla-Zancada, M A Prieto-Díaz, C Escobar-Cervantes, et al.
Pharmacology & Therapeutics|January 21, 2026
Therapeutic potential of targeting novel signaling pathways in regulating chronic inflammation in obstructive lung disordersDan Li, Ana L Manzano-Covarrubias, Kelly B I Douglas, et al.
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Critical Care Medicine|June 1, 1989
Pulmonary hypertension in acute respiratory failureJ Villar, M A Blazquez, S Lubillo, et al.
European Urology|January 1, 1997
T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activatedE Reyes, J Carballido, A Prieto, et al.
Revista Clinica Espanola|April 1, 1996
[Mounier-Kuhn syndrome. 2 representative cases of its clinical spectrum]J A Arranz Caso, J Fernández Francés, D Jiménez Jurado, et al.
British Journal of Cancer|January 1, 1997
Prophylactic intracavitary treatment with interferon alpha increases interferon gamma production by peripheral blood mononuclear cells in patients with superficial transitional cell carcinoma of the bladderL Moltó, J Carballido, L Manzano, et al.
British Journal of Cancer|March 31, 1999
The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patientsE Reyes, J Carballido, L Manzano, et al.
Cancer|June 1, 1995
Use of intracavitary interferon-alpha-2b in the prophylactic treatment of patients with superficial bladder cancerL Moltó, M Alvarez-Mon, J Carballido, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1994
Interferon beta enhances the natural killer activity of patients with bladder carcinomaL Moltó, J Carballido, L Manzano, et al.
Anti-Cancer Drugs|May 1, 1992
Immunomodulatory effect of interferon-alpha 2b on natural killer cells and T lymphocytes from patients with transitional cell carcinoma of the bladderM Alvarez-Mon, L M Moltó, L Manzano, et al.
Semergen|November 21, 2016
[Orthostatic hypotension; that great unknown]S M Velilla-Zancada, M A Prieto-Díaz, C Escobar-Cervantes, et al.
Pharmacology & Therapeutics|January 21, 2026
Therapeutic potential of targeting novel signaling pathways in regulating chronic inflammation in obstructive lung disordersDan Li, Ana L Manzano-Covarrubias, Kelly B I Douglas, et al.
Pageof 18